A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin

Youn Ho Kim, Woo Sik Han, Sun Jae Lee, Sung Nam Oh, Do Won Choi, Kwan Soo Byun, Jong Eun Yeon

Research output: Contribution to journalArticle

Abstract

There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN plus ribavirin combination therapy are bone marrow suppression and hemolytic anemia. However, there are few reports of vasculitis occurring during PEG-IFN therapy. We describe a patient who developed vasculitis during the treatment of chronic hepatitis C with PEG-IFN and ribavirin.

Original languageEnglish
Pages (from-to)419-422
Number of pages4
JournalThe Korean journal of hepatology
Volume13
Issue number3
DOIs
Publication statusPublished - 2007 Sep

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin'. Together they form a unique fingerprint.

  • Cite this